Literature DB >> 31884487

The Prevalence of Dementia: A Systematic Review and Meta-Analysis.

Qing Cao1, Chen-Chen Tan2, Wei Xu2, Hao Hu2, Xi-Peng Cao3, Qiang Dong4, Lan Tan1, Jin-Tai Yu4.   

Abstract

Dementia is a severe neurodegenerative disorder and it can be categorized into several subtypes by different pathogenic causes. We sought to comprehensively analyzed the prevalence of dementia from perspectives of geographic region (Asia, Africa, South America, and Europe/North America), age, and gender. We searched PubMed and EMBASE for relevant articles on dementia published from January 1985 to August 2019. In these studies, analyses were stratified by geographic region, age, and gender. Meta-regression was conducted to identify if there were significant differences between groups. We included forty-seven studies. Among the individuals aged 50 and over in the community, the pooled prevalence for all-cause dementia, Alzheimer's disease, and vascular dementia were 697 (CI95%: 546-864) per 10,000 persons, 324 (CI95%: 228-460) per 10,000 persons, and 116 (CI95%: 86-157) per 10,000 persons, respectively. In our study, the prevalence of all-type dementia in individuals aged 100 years and older (6,592 per 10,000 cases) is 244 times higher than in those aged 50-59 (27 per 10,000 cases). The number of people living with dementia approximately doubles every five years. The prevalence was greater in women than in men (788 cases versus 561 cases per 10,000 persons) in overall analysis. In individuals aged 60 to 69 years, AD prevalence in females was 1.9 times greater than that in males (108 cases versus 56 cases per 10,000 persons), while the prevalence of VaD was 1.8 times greater in males than in females (56 cases versus 32 cases per 10,000 persons). Prevalence rate was higher in Europe and North America than in Asia, Africa, and South America.

Entities:  

Keywords:  Alzheimer’s disease; dementia; prevalence; vascular dementia

Mesh:

Year:  2020        PMID: 31884487     DOI: 10.3233/JAD-191092

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  37 in total

1.  Distal radius fractures and risk of incident neurocognitive disorders in older adults: a retrospective cohort study.

Authors:  Joshua M Baruth; Maria I Lapid; Bart Clarke; Alexander Y Shin; Elizabeth J Atkinson; Jonas Eberhard; Guido Zavatta; Jörgen Åstrand
Journal:  Osteoporos Int       Date:  2022-07-15       Impact factor: 5.071

Review 2.  Hibiscus, Rooibos, and Yerba Mate for Healthy Aging: A Review on the Attenuation of In Vitro and In Vivo Markers Related to Oxidative Stress, Glycoxidation, and Neurodegeneration.

Authors:  Matheus Thomaz Nogueira Silva Lima; Eric Boulanger; Frédéric J Tessier; Jacqueline Aparecida Takahashi
Journal:  Foods       Date:  2022-06-07

Review 3.  Bridging the Gap: A Geroscience Primer for Neuroscientists With Potential Collaborative Applications.

Authors:  Jessica M Hoffman; Caesar M Hernandez; Abbi R Hernandez; Jennifer L Bizon; Sara N Burke; Christy S Carter; Thomas W Buford
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2022-01-07       Impact factor: 6.591

Review 4.  Estradiol and Estrogen-like Alternative Therapies in Use: The Importance of the Selective and Non-Classical Actions.

Authors:  Szidónia Farkas; Adrienn Szabó; Anita Emőke Hegyi; Bibiána Török; Csilla Lea Fazekas; Dávid Ernszt; Tamás Kovács; Dóra Zelena
Journal:  Biomedicines       Date:  2022-04-06

5.  Current and Future Prevalence Estimates of Mild Cognitive Impairment, Dementia, and Its Subtypes in a Population-Based Sample of People 70 Years and Older in Norway: The HUNT Study.

Authors:  Linda GjØra; BjØrn Heine Strand; Sverre Bergh; Tom Borza; Anne Brækhus; Knut Engedal; Aud Johannessen; Marte Kvello-Alme; Steinar Krokstad; Gill Livingston; Fiona E Matthews; Christian Myrstad; Håvard Skjellegrind; Pernille Thingstad; Eivind Aakhus; Stina Aam; Geir Selbæk
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

6.  Association of sex differences in dementia risk factors with sex differences in memory decline in a population-based cohort spanning 20-76 years.

Authors:  Kaarin J Anstey; Ruth Peters; Moyra E Mortby; Kim M Kiely; Ranmalee Eramudugolla; Nicolas Cherbuin; Md Hamidul Huque; Roger A Dixon
Journal:  Sci Rep       Date:  2021-04-08       Impact factor: 4.379

7.  Proton pump inhibitors and the risk of Alzheimer's disease and non-Alzheimer's dementias.

Authors:  Francisco Torres-Bondia; Farida Dakterzada; Leonardo Galván; Miquel Buti; Gaston Besanson; Eric Gill; Roman Buil; Jordi de Batlle; Gerard Piñol-Ripoll
Journal:  Sci Rep       Date:  2020-12-03       Impact factor: 4.379

Review 8.  microRNA-Based Biomarkers in Alzheimer's Disease (AD).

Authors:  Yuhai Zhao; Vivian Jaber; Peter N Alexandrov; Andrea Vergallo; Simone Lista; Harald Hampel; Walter J Lukiw
Journal:  Front Neurosci       Date:  2020-10-30       Impact factor: 4.677

9.  The Leukotriene Receptor Antagonist Montelukast Attenuates Neuroinflammation and Affects Cognition in Transgenic 5xFAD Mice.

Authors:  Johanna Michael; Julia Zirknitzer; Michael Stefan Unger; Rodolphe Poupardin; Tanja Rieß; Nadine Paiement; Horst Zerbe; Birgit Hutter-Paier; Herbert Reitsamer; Ludwig Aigner
Journal:  Int J Mol Sci       Date:  2021-03-09       Impact factor: 5.923

10.  Efficacy of Yukmijihwang-tang on symptoms of Alzheimer disease: A protocol for systematic review and meta-analysis.

Authors:  Seunghee Lee; Do Hyung Kwon; Ju Yeon Kim; Yunna Kim; Seung-Hun Cho; In Chul Jung
Journal:  Medicine (Baltimore)       Date:  2021-06-25       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.